Systematic statistical analysis of change in <scp>SEIzure interVAL</scp> with diazepam nasal spray supports this novel clinical endpoint for immediate‐use seizure medication

This systematically planned analysis expands on and reinforces the previous pragmatic analysis that introduced the SEIVAL metric. The present analysis provides a novel framework for future studies of intermittently administered ISMs to treat seizure clusters such as diazepam nasal spray.